APA (7th ed.) Citation

Khan, F., Ottensmeier, C., Popat, S., Dua, D., Dorey, N., Ellis, S., . . . Danson, S. (2014). Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme. European Journal of Cancer, 50(10), 1717. https://doi.org/10.1016/j.ejca.2014.03.001

Chicago Style (17th ed.) Citation

Khan, F., et al. "Afatinib Use in Non-small Cell Lung Cancer Previously Sensitive to Epidermal Growth Factor Receptor Inhibitors: The United Kingdom Named Patient Programme." European Journal of Cancer 50, no. 10 (2014): 1717. https://doi.org/10.1016/j.ejca.2014.03.001.

MLA (9th ed.) Citation

Khan, F., et al. "Afatinib Use in Non-small Cell Lung Cancer Previously Sensitive to Epidermal Growth Factor Receptor Inhibitors: The United Kingdom Named Patient Programme." European Journal of Cancer, vol. 50, no. 10, 2014, p. 1717, https://doi.org/10.1016/j.ejca.2014.03.001.